Roivant Sciences Email Format

Biotechnology ResearchNew York, United States201-500 Employees

Roivant Sciences is a biotechnology research company headquartered in New York, New York. The organization creates Vants, nimble biotech and healthcare technology companies, with a focus on sourcing talent, aligning incentives, and deploying technology. Its therapies across the Roivant family of companies target conditions including uterine fibroids, endometriosis, prostate cancer, Parkinson's disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric diseases, prioritizing areas with relatively low pharmaceutical R&D investment relative to medical need. In addition to biopharmaceutical subsidiaries, Roivant develops technology-focused Vants intended to improve the process of developing and commercializing medicines. The company employs 201–500 people and reports revenue in the range of $100–$250 million.

Sign up for free to view info

Company overview Employee directory